The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
Another Nitrosamine Recall. Another Reminder That This Problem Isn’t Going Away.
Read More
case-study
Zero Questions: A Phase 2 IND, Two Tech Transfers, and a 10-Person Biotech
Read More
case-study
From CRL to Approval: End-to-End BLA Lifecycle Support for a Phase 3 Biologic Program
Read More
infographic
Rethinking Toxicology: Smarter Paths Beyond Animal Testing
Read More
Let's move from science to success.
Let’s Talk